The Spectator magazine combines incisive political analysis with books and arts reviews of unrivaled authority. absolutely free. Go to spectator.com.uk forward slash voucher.

Hello and welcome to Coffeehouse Shots for Spectators' Daily Politics Podcasts. I'm Isabel Hardman

and I'm joined by James Forsyth and Katie Balls. Well, there's a row, several rows, in fact,

in the European Union over vaccinations.

James, the EU has told Pfizer to warn them when they start giving more jabs to Britain.

Explain a little bit more about what's going on and why here.

The EU's vaccination programme has not got off to a rapid start.

It isn't vaccinating at the pace that the UK is or the US is.

And I think that is causing tensions in the bloc and the EU is trying to get on the front foot.

It had a big blow recently because Pfizer and Bioentec who produced a vaccine in Belgium

announced they were going to refit the factory there to try and increase supply.

That was going to lead, though, to a temporary reduction in supply.

Then much to the EU's annoyance, AstraZeneca, whose Oxford Astrosenica Zab has not yet been

approved by the European regulator, but that's expected to be approved this week, said that they

were cutting their supplies to the EU by 60%. And the EU were very cross about that. And I think what

the EU is trying to do is it's trying to say to,

it's plan that you have to notify them before you export COVID vaccine. It's trying to ensure

that it basically gets first dibs on the vaccine made in the EU. So, for example, on Pfizer biotech,

if Pfizer hadn't delivered everything to the EU,

I think the EU would object to them fulfilling their contractual obligations to the UK by exporting there.

At the moment, the EU is stressing this is purely about notification to ensure that they get what their contractual entitled to.

But it's very easy to see how this could turn into a situation like it did with PPE last spring,

...